FOOT ANKLE SURG 润色咨询

Foot and Ankle Surgery

出版年份:暂无数据 年文章数:1078 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:2.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=847390, encodeId=255b84e3908a, content=审稿速度:2.0<br>经验分享:投稿一个月后修回,两天修改完后重新提交,现在等待消息中。杂志感觉挺好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Sat Sep 22 22:55:32 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106495, encodeId=ceda1106495f3, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106496, encodeId=925411064969d, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846585, encodeId=1b8284658554, content=骨科期刊就那样,分最高的几个也高不了多少,不如多投几个低分的容易些。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Aug 24 14:00:08 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-09-22 ms9001418248751590

    审稿速度:2.0
    经验分享:投稿一个月后修回,两天修改完后重新提交,现在等待消息中。杂志感觉挺好

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=847390, encodeId=255b84e3908a, content=审稿速度:2.0<br>经验分享:投稿一个月后修回,两天修改完后重新提交,现在等待消息中。杂志感觉挺好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Sat Sep 22 22:55:32 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106495, encodeId=ceda1106495f3, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106496, encodeId=925411064969d, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846585, encodeId=1b8284658554, content=骨科期刊就那样,分最高的几个也高不了多少,不如多投几个低分的容易些。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Aug 24 14:00:08 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    是否需要在讨论中说明文章局限性?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=847390, encodeId=255b84e3908a, content=审稿速度:2.0<br>经验分享:投稿一个月后修回,两天修改完后重新提交,现在等待消息中。杂志感觉挺好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Sat Sep 22 22:55:32 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106495, encodeId=ceda1106495f3, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106496, encodeId=925411064969d, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846585, encodeId=1b8284658554, content=骨科期刊就那样,分最高的几个也高不了多少,不如多投几个低分的容易些。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Aug 24 14:00:08 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    讨论中局限性怎么撰写?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=847390, encodeId=255b84e3908a, content=审稿速度:2.0<br>经验分享:投稿一个月后修回,两天修改完后重新提交,现在等待消息中。杂志感觉挺好 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Sat Sep 22 22:55:32 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106495, encodeId=ceda1106495f3, content=是否需要在讨论中说明文章局限性?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106496, encodeId=925411064969d, content=讨论中局限性怎么撰写?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846585, encodeId=1b8284658554, content=骨科期刊就那样,分最高的几个也高不了多少,不如多投几个低分的容易些。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df4c5413960, createdName=ms8480212230682571, createdTime=Fri Aug 24 14:00:08 CST 2018, time=2018-08-24, status=1, ipAttribution=)]
    2018-08-24 ms8480212230682571

    骨科期刊就那样,分最高的几个也高不了多少,不如多投几个低分的容易些。

    0

共7条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分